0001077183-19-000230.txt : 20191212 0001077183-19-000230.hdr.sgml : 20191212 20191212192827 ACCESSION NUMBER: 0001077183-19-000230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191210 FILED AS OF DATE: 20191212 DATE AS OF CHANGE: 20191212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKenzie Kathryn B CENTRAL INDEX KEY: 0001720001 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 191283005 MAIL ADDRESS: STREET 1: 12780 WESTLINKS DRIVE CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_157619689019440.xml FORM 4 X0306 4 2019-12-10 0 0001077183 NEOGENOMICS INC NEO 0001720001 McKenzie Kathryn B 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 Chief Accounting Officer Common Stock 2019-12-10 4 M 0 8000 8.03 A 10273 D Common Stock 2019-12-10 4 S 0 8000 26.37 D 2273 D Stock Option (Right to Buy) 8.03 2019-12-10 4 M 0 8000 0 D 2019-02-26 2023-02-26 Common Stock 8000.0 40000 D Stock Option (Right to Buy) 9.07 2018-10-18 2022-10-18 Common Stock 25000.0 25000 D Stock Option (Right to Buy) 19.6 2020-03-01 2024-03-01 Common Stock 13894.0 13894 D On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date. /s/ Kathryn McKenzie 2019-12-12